The FDA is adding a warning to all prescription testosterone products regarding abuse and dependence risks. Prescription testosterone was already designated a Schedule III controlled substance due to safety risks impacting the heart, brain, liver, mental health and endocrine system if taken more than directed. Additional case reports indicate that abuse of testosterone can lead to withdrawal symptoms such as depression, fatigue, irritability, loss of appetite, decreased libido and insomnia. Testosterone is prescribed to men as hormone replacement therapy, usually due to medical conditions such as genetic issues or chemotherapy. Posted October 25, 2016. Via FDA.
Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.
Did you find this article helpful?
No votes so far! Be the first to rate this post.